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Bariatric surgery is an effective treatment for morbid obesity with
a sustained weight loss and improvements in metabolic syndrome.
We present a label free quantitative shotgun proteomics approach
to analyze the serum proteome of obese people who underwent
Laparoscopic Gastric Plication (LGP) as a new bariatric surgery.
Pre-surgery serum samples of obese individuals were compared
with the serum of the same subjects 1e2 months post-surgery
(T1) and 4e5 months post-surgery (T2). The data provide a list
of 224 quantifiable proteins with at least two unique peptides that
were quantifiable in at least 70% of samples. Gene ontology bio-
logical processes and molecular functions of differentially regu-
lated proteins between pre- and post-surgery samples were
investigated using WebGestalt online tool. In addition, molecular
networks of differentially abundant proteins were determined
through Ingenuity Pathway Analysis (IPA) software. This report is
related to the research article entitled “Serum proteome changes
and accelerated reduction of fat mass after Laparoscopic Gastric
Plication in morbidly obese patients” (Savedoroudi et al. [1]).
Proteomics data have been deposited to the ProteomeXchangej.jprot.2019.05.001.
ience and Technology, Fredrik Bajers Vej 7, E4-114 9220, Aalborg, Denmark.
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Value of the data
 These data reveal the effect of laparoscopic ga
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y, Denmark.
within this article and from ProteomeXchange Consortium (http://
proteomexchange.org) via the PRIDE partner repository with the dataset
identifier PXD010528.stric plication (LGP) on the proteome profile of obese people for the first
the biological processes, molecular functions and molecular networks of
and post-surgery subjects.
underlying molecular mechanism associated with laparoscopic gastric
in development of non-surgical weight loss strategies.1. Data
This report is associatedwith the research article aimed at investigating the effect of weight loss due
to laparoscopic gastric plication (LGP) as a new bariatric surgical procedure on the human serum
proteome [1]. A total of 288 proteins was identified using a shotgun label-free proteomics experiment,
of which 224 proteins were quantifiable with at least two unique peptides in 70% of samples or more
(Supplementary Table 1). The rawmass data have been deposited to the ProteomeXchange Consortium
(http://proteomecentral.proteomexchange.org) via the PRIDE partner repository [2] with the dataset
identifier PXD010528. The list of submitted proteomics raw-files into the ProteomeXchange and cor-
responding sample names are shown in Table 1. Significantly regulated proteins between pre- and
post-surgery samples were discussed in detail in Savedoroudi et al. [1]. Gene ontology enrichment
analysis for biological process and molecular function of differentially regulated proteins at T1 and T2
are represented in Table 2 and Table 3, respectively. In Table 4, molecular networks of differentially
regulated proteins are shown.
Table 1
Description of file-names and MaxQuant output in the ProteomeXchange repository PXD010528. MS files were analyzed in
MaxQuant. All samples were analyzed in triplicates. Timepoint 1: 1e2 months post-surgery; Timepoint 2: 4e5 months post-
surgery.
Raw file Sample MS system
2bef-1 2/Before surgery Q Exactive HF
2bef-2 2/Before surgery Q Exactive HF
2bef-3 2/Before surgery Q Exactive HF
2aft1-1 2/After surgery at timepoint 1 Q Exactive HF
2aft1-2 2/After surgery at timepoint 1 Q Exactive HF
2aft1-3 2/After surgery at timepoint 1 Q Exactive HF
3bef-1 3/Before surgery Q Exactive HF
3bef-2 3/Before surgery Q Exactive HF
3bef-3 3/Before surgery Q Exactive HF
3aft1-1 3/After surgery at timepoint 1 Q Exactive HF
3aft1-2 3/After surgery at timepoint 1 Q Exactive HF
3aft1-3_170725101835 3/After surgery at timepoint 1 Q Exactive HF
3aft2-1 3/After surgery at timepoint 2 Q Exactive HF
3aft2-2 3/After surgery at timepoint 2 Q Exactive HF
3aft2-3 3/After surgery at timepoint 2 Q Exactive HF
4bef-1 4/Before surgery Q Exactive HF
4bef-2 4/Before surgery Q Exactive HF
4bef-3 4/Before surgery Q Exactive HF
4aft1-1 4/After surgery at timepoint 1 Q Exactive HF
4aft1-2 4/After surgery at timepoint 1 Q Exactive HF
4aft1-3 4/After surgery at timepoint 1 Q Exactive HF
5bef-1 5/Before surgery Q Exactive HF
5bef-2 5/Before surgery Q Exactive HF
5bef-3 5/Before surgery Q Exactive HF
5aft1-1 5/After surgery at timepoint 1 Q Exactive HF
5aft1-2 5/After surgery at timepoint 1 Q Exactive HF
5aft1-3 5/After surgery at timepoint 1 Q Exactive HF
5aft2-1 5/After surgery at timepoint 2 Q Exactive HF
5aft2-2 5/After surgery at timepoint 2 Q Exactive HF
5aft2-3 5/After surgery at timepoint 2 Q Exactive HF
6bef-1 6/Before surgery Q Exactive HF
6bef-2 6/Before surgery Q Exactive HF
6bef-3 6/Before surgery Q Exactive HF
6aft1-1 6/After surgery at timepoint 1 Q Exactive HF
6aft1-2 6/After surgery at timepoint 1 Q Exactive HF
6aft1-3 6/After surgery at timepoint 1 Q Exactive HF
6aft2-1 6/After surgery at timepoint 2 Q Exactive HF
6aft2-2 6/After surgery at timepoint 2 Q Exactive HF
6aft2-3 6/After surgery at timepoint 2 Q Exactive HF
7bef-1 7/Before surgery Q Exactive HF
7bef-2 7/Before surgery Q Exactive HF
7bef-3 7/Before surgery Q Exactive HF
7aft1-1 7/After surgery at timepoint 1 Q Exactive HF
7aft1-2 7/After surgery at timepoint 1 Q Exactive HF
7aft1-3 7/After surgery at timepoint 1 Q Exactive HF
7aft2-1 7/After surgery at timepoint 2 Q Exactive HF
7aft2-2 7/After surgery at timepoint 2 Q Exactive HF
7aft2-3 7/After surgery at timepoint 2 Q Exactive HF
8bef-1 8/Before surgery Q Exactive HF
8bef-2 8/Before surgery Q Exactive HF
8bef-3 8/Before surgery Q Exactive HF
8aft1-1 8/After surgery at timepoint 1 Q Exactive HF
8aft1-2 8/After surgery at timepoint 1 Q Exactive HF
8aft1-3_170725085836 8/After surgery at timepoint 1 Q Exactive HF
8aft2-1 8/After surgery at timepoint 2 Q Exactive HF
8aft2-2 8/After surgery at timepoint 2 Q Exactive HF
8aft2-3 8/After surgery at timepoint 2 Q Exactive HF
9bef-1 9/Before surgery Q Exactive HF
(continued on next page)
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Table 1 (continued )
Raw file Sample MS system
9bef-2 9/Before surgery Q Exactive HF
9bef-3 9/Before surgery Q Exactive HF
9aft1-1 9/After surgery at timepoint 1 Q Exactive HF
9aft1-2 9/After surgery at timepoint 1 Q Exactive HF
9aft1-3 9/After surgery at timepoint 1 Q Exactive HF
10bef-1 10/Before surgery Q Exactive HF
10bef-2 10/Before surgery Q Exactive HF
10bef-3 10/Before surgery Q Exactive HF
10aft1-1 10/After surgery at timepoint 1 Q Exactive HF
10aft1-2 10/After surgery at timepoint 1 Q Exactive HF
10aft1-3 10/After surgery at timepoint 1 Q Exactive HF
10aft2-1 10/After surgery at timepoint 2 Q Exactive HF
10aft2-2 10/After surgery at timepoint 2 Q Exactive HF
10aft2-3 10/After surgery at timepoint 2 Q Exactive HF
11bef-1 11/Before surgery Q Exactive HF
11bef-2 11/Before surgery Q Exactive HF
11bef-3 11/Before surgery Q Exactive HF
11aft1-1 11/After surgery at timepoint 1 Q Exactive HF
11aft1-2 11/After surgery at timepoint 1 Q Exactive HF
11aft1-3 11/After surgery at timepoint 1 Q Exactive HF
11aft2-1 11/After surgery at timepoint 2 Q Exactive HF
11aft2-2 11/After surgery at timepoint 2 Q Exactive HF
11aft2-3 11/After surgery at timepoint 2 Q Exactive HF
12bef-1 12/Before surgery Q Exactive HF
12bef-2 12/Before surgery Q Exactive HF
12bef-3 12/Before surgery Q Exactive HF
12aft1-1 12/After surgery at timepoint 1 Q Exactive HF
12aft1-2 12/After surgery at timepoint 1 Q Exactive HF
12aft1-3 12/After surgery at timepoint 1 Q Exactive HF
14bef-1 14/Before surgery Q Exactive HF
14bef-2 14/Before surgery Q Exactive HF
14bef-3 14/Before surgery Q Exactive HF
14aft1-1 14/After surgery at timepoint 1 Q Exactive HF
14aft1-2 14/After surgery at timepoint 1 Q Exactive HF
14aft1-3 14/After surgery at timepoint 1 Q Exactive HF
14aft2-1 14/After surgery at timepoint 2 Q Exactive HF
14aft2-2 14/After surgery at timepoint 2 Q Exactive HF
14aft2-3 14/After surgery at timepoint 2 Q Exactive HF
15bef-1 15/Before surgery Q Exactive HF
15bef-2 15/Before surgery Q Exactive HF
15bef-3 15/Before surgery Q Exactive HF
15aft1-1 15/After surgery at timepoint 1 Q Exactive HF
15aft1-2 15/After surgery at timepoint 1 Q Exactive HF
15aft1-3 15/After surgery at timepoint 1 Q Exactive HF
17bef-1 17/Before surgery Q Exactive HF
17bef-2 17/Before surgery Q Exactive HF
17bef-3 17/Before surgery Q Exactive HF
17aft1-1 17/After surgery at timepoint 1 Q Exactive HF
17aft1-2 17/After surgery at timepoint 1 Q Exactive HF
17aft1-3 17/After surgery at timepoint 1 Q Exactive HF
17aft2-1 17/After surgery at timepoint 2 Q Exactive HF
17aft2-2 17/After surgery at timepoint 2 Q Exactive HF
17aft2-3 17/After surgery at timepoint 2 Q Exactive HF
18bef-1 18/Before surgery Q Exactive HF
18bef-2 18/Before surgery Q Exactive HF
18bef-3 18/Before surgery Q Exactive HF
18aft1-1 18/After surgery at timepoint 1 Q Exactive HF
18aft1-2 18/After surgery at timepoint 1 Q Exactive HF
18aft1-3 18/After surgery at timepoint 1 Q Exactive HF
21bef-1 21/Before surgery Q Exactive HF
21bef-2 21/Before surgery Q Exactive HF
21bef-3 21/Before surgery Q Exactive HF
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Table 1 (continued )
Raw file Sample MS system
21aft1-1 21/After surgery at timepoint 1 Q Exactive HF
21aft1-2 21/After surgery at timepoint 1 Q Exactive HF
21aft1-3 21/After surgery at timepoint 1 Q Exactive HF
The MaxQuant output in folder "txt" contains a range of files containing important search information. Below file
was used for further processing in Perseus post-analysis program and quantitative analysis.
proteinGroups.txt File containing all proteins with corresponding label free quantitative information
P. Savedoroudi et al. / Data in brief 25 (2019) 104077 52. Experimental design, materials and methods
2.1. Study cohort and sample treatment
A total of 16 obese subjects undergoing LGP was investigated at three timepoints; pre-surgery
(n ¼ 16), at 1e2 months post-surgery (T1, n ¼ 16), at 4e5 months post-surgery (T2, n ¼ 9). The
detailed characteristics of patients were mentioned in Savedoroudi et al. [1]. The six most abundant
serum proteins (albumin, IgG, IgA, antitrypsin, transferrin and haptoglobin) were depleted in the
serum samples using the Agilent Multiple Affinity Removal column (4.6  50 mm) according to the
instructions recommended by the manufacturers (Agilent Technologies, CA, USA). Then, the filter-
aided sample preparation (FASP) protocol was utilized to prepare samples as described previously
[1,3]. Written consent was obtained from all participants and the institutional review board and theTable 2
Enrichment analysis of Gene ontology biological process and molecular function for differentially abundant proteins at T1, using
WebGestalt online tool.
Gen set Description P-value Overlap Gen-ID
Biological Process
GO:0051223 regulation of protein transport 4.87E-05 CRP, GPLD1, APOA1, APOA2, APOD, IL1RAP, LCP1, SRGN, RBP4,
SAA1, CD14, ADIPOQ
GO:0070201 regulation of establishment of
protein localization
8.84E-05 CRP, GPLD1, APOA1, APOA2, APOD, IL1RAP, LCP1, SRGN, RBP4,
SAA1, CD14, ADIPOQ
GO:0034284 response to monosaccharide 0.000109 GPLD1, APOA2, SERPINF1, APOM, SPARC, THBS1, ADIPOQ
GO:0032880 regulation of protein
localization
0.000256 CRP, GPLD1, APOA1, APOA2, APOD, IL1RAP, LCP1, SRGN, RBP4,
SAA1, CD14, ADIPOQ
GO:0009743 response to carbohydrate 0.000315 GPLD1, APOA2, SERPINF1, APOM, SPARC, THBS1, ADIPOQ
GO:0009746 response to hexose 0.000532 GPLD1, APOA2, SERPINF1, APOM, THBS1, ADIPOQ
GO:0009749 response to glucose 0.000532 GPLD1, APOA2, SERPINF1, APOM, THBS1, ADIPOQ
GO:0050707 regulation of cytokine secretion 0.000746 CRP, APOA1, APOA2, IL1RAP, SRGN, SAA1, CD14
GO:0051224 negative regulation of protein
transport
0.00081 APOA1, APOA2, APOD, SRGN, ADIPOQ
GO:1904950 negative regulation of
establishment of protein
localization
0.00081 APOA1, APOA2, APOD, SRGN, ADIPOQ
Molecular Function
GO:0005319 lipid transporter activity 0.00279 APOF, APOA1, APOA2, APOD, APOM, RBP4
GO:0005496 steroid binding 0.00279 GC, APOF, APOA1, APOA2, APOD, SHBG
GO:0071813 lipoprotein particle binding 0.0101 CRP, APOA1, APOA2, THBS1
GO:0071814 protein-lipid complex binding 0.0101 CRP, APOA1, APOA2, THBS1
GO:0043178 alcohol binding 0.0105 APOF, APOA1, APOA2, APOD, RBP4
GO:0008289 lipid binding 0.0122 F10, GC, APOF, APOA1, APOA2, APOD, APOM, RBP4, SHBG,
THBS1, CD14
GO:0005215 transporter activity 0.0128 GC, HBB, APOF, APOA1, APOA2, APOD, APOM, RBP4
GO:0022892 substrate-specific transporter
activity
0.0170 HBB, APOF, APOA1, APOA2, APOD, APOM, RBP4
GO:0015485 cholesterol binding 0.0206 APOF, APOA1, APOA2, APOD
GO:0032934 sterol binding 0.0206 APOF, APOA1, APOA2, APOD
Table 3
Enrichment analysis of Gene ontology biological process and molecular function for differentially abundant proteins at T2, using
WebGestalt online tool.
Gen set Description P-value Overlap Gen-ID
Biological Process
GO:0010976 positive regulation of neuron projection development 0.000151 FN1, IL1RAP, NRP1
GO:0045666 positive regulation of neuron differentiation 0.000151 FN1, IL1RAP, NRP1
GO:0050769 positive regulation of neurogenesis 0.000151 FN1, IL1RAP, NRP1
GO:0051962 positive regulation of nervous system development 0.000151 FN1, IL1RAP, NRP1
GO:0010975 regulation of neuron projection development 0.000262 FN1, IL1RAP, NRP1
GO:0031346 positive regulation of cell projection organization 0.000416 FN1, IL1RAP, NRP1
GO:0045664 regulation of neuron differentiation 0.000416 FN1, IL1RAP, NRP1
GO:0050767 regulation of neurogenesis 0.000618 FN1, IL1RAP, NRP1
GO:0051960 regulation of nervous system development 0.000618 FN1, IL1RAP, NRP1
GO:0031344 regulation of cell projection organization 0.00119 FN1, IL1RAP, NRP1
Molecular Function
GO:0004888 transmembrane signaling receptor activity 0.0226 IL1RAP, NRP1
GO:0099600 transmembrane receptor activity 0.0226 IL1RAP, NRP1
GO:0004872 receptor activity 0.0304 PRG4, IL1RAP, NRP1
GO:0060089 molecular transducer activity 0.0304 PRG4, IL1RAP, NRP1
GO:0038023 signaling receptor activity 0.0336 IL1RAP, NRP1
GO:0004871 signal transducer activity 0.0533 IL1RAP, NRP1
GO:0016301 kinase activity 0.135 NRP1
GO:0016504 peptidase activator activity 0.135 FN1
GO:0016772 transferase activity, transferring phosphorus-containing groups 0.135 NRP1
GO:0016773 phosphotransferase activity, alcohol group as acceptor 0.135 NRP1
P. Savedoroudi et al. / Data in brief 25 (2019) 1040776ethic committee of Shahid Beheshti University approved the study protocol for Human rights (IR.S-
BU.ICBS.97/1019).
2.2. LC-MS/MS analysis
Initially, the peptides were resuspended in 2% acetonitrile, 0.1% FA and 0.1% trifluoroacetic acid. LC-
MS/MS analysis was carried out on a UPLC-nanoESI MS/MS setup with a Dionex RSLC nanopump
(Dionex, CA, USA). The system was coupled online with an emitter for nanospray ionization (New
objective picotip 360-20-10) to a Q Exactive HF mass spectrometer (Thermo Scientific, Waltham, USA).
The samples were analyzed in a random order, in triplicates. The peptide material was loaded onto a
2cm C18 trapping column (Dionex Acclaim PepMap RSLC C18) and separated using a 75cm C18
reversed-phase column (Dionex Acclaim PepMap RSLC C18). Both columns were kept at 60 C. The
peptides were eluted with a gradient of 98% solvent A (0.1% FA) and 2% solvent B (0.1% FA in aceto-
nitrile), whichwas increased to 8% solvent B on a 5-min ramp gradient and subsequently to 30% solvent
B on a 45-min ramp gradient, at a constant flow rate of 300nL/min. The mass spectrometer was
operated in positive mode using a Top15 data-dependent MS/MS scan method. A full MS scan in the
375e1500 m/z range was acquired at a resolution of 120 000 with an AGC target of 3  106 and a
maximum injection time of 50 ms. Fragmentation of precursor ions was performed by higher-energy
C-trap dissociationwith a normalized collision energy of 27. MS/MS scans were acquired at a resolution
of 15000 with an AGC target of 2  105; maximum injection time was 100 ms. Dynamic exclusion was
set to 5s.
2.3. Data analysis and processing
Mass spectrometry data were analyzed in MaxQuant version 1.6.0.1 and searched against the
Uniprot human reference FASTA database (August 2017) [4,5]. Label-free protein quantitation (LFQ)
algorithm was performed with a minimum ratio count of 1. Standard settings in MaxQuant were
employed, including carbamidomethylation of cysteines as a fixed modification, and acetylation of
protein N-terminals, oxidation of methionine, and deamidation of asparagine and glutamine as
Table 4
Networks identified using IPA.
Top Diseases and Functions Score Focus
Molecules
Molecules in Network
T1
Lipid Metabolism, Molecular
Transport, Small Molecule
Biochemistry
45 19 Adipokine, ADIPOQ, APCS, APOA1, APOA2, APOA4, APOD, APOF, APOM,
C1q, C4BP, C4BPA, Collagen type II, CRP, ERK1/2, F10, Fibrinogen, GC,
GPLD1, Growth hormone, HDL, HDL-cholesterol, Histone h4, IL12
(complex), LDL, NADPH oxidase, Pro-inflammatory Cytokine, RARRES2,
Rbp, RBP4, SAA1, SERPINF1, SERPINF2, Sod, TTR
Cardiovascular System
Development and Function,
Cellular Movement, Cell-To-
Cell Signaling and Interaction
28 13 Akt, Ap1, collagen, Collagen Alpha1, Collagen type I, Collagen type IV,
Collagen type VI, Collagen(s), DBH, DSG2, elastase, Fc gamma receptor,
GP1BA, Gp2b3a Receptor, IL1, IL-1R, IL1RAP, Integrin, Iti, ITIH2, ITIH3,
Laminin (complex), LCP1, Mek, Mmp, MMP9, p85 (pik3r), Pdgf
(complex), PDGF BB, PEPD, SPARC, SRGN, Tgf beta, THBS1, VWF
Cellular Assembly and
Organization, Nervous
System Development and
Function, Cell-To-Cell
Signaling and Interaction
18 9 CD14, CFP, Cg, Creb, CRTAC1, ERK, estrogen receptor, F7, FAH, GOT, HBB,
HISTONE, Histone h3, Ifn, IFN Beta, Ige, IgG, IgG1, IL12 (family),
Immunoglobulin, Insulin, Mapk, NFkB (complex), NRP1, P38MAPK, PI3K
(complex), Pka, PRG4, Rac, RNA polymerase II, SHBG, SRC (family), TCF,
Tnf (family), Vegf
Cell-To-Cell Signaling and
Interaction, Hematological
System Development and
Function, Immune Cell
Trafficking
15 8 ACTG2, Actin, APCS, APP, C7, CASP8, caspase, CCL17, CD3, CFI, CLEC10A,
CNDP1, CTF1, CYTIP, Ddx3x, DEFA6, Dstn/Dstnl1, FETUB, Granzyme,
HBG1, IL13, IL10RB, Jnk, LIPA, LRP1, MMRN1, MT1G, PZP, Ras, S100A12,
SCAVENGER receptor CLASS A, Sos, SRGN, TCR, ZFP36L1
Inflammatory Response,
Infectious Diseases,
Inflammatory Disease
5 3 ADIPOR2, APCS, BBS12, CD163, CD276, CLEC10A, CMKLR1, coagulation
factor, CYP19, CYTIP, estrone, FBXO42, Fcgr2, FSH,
glycosylphosphatidylinositol, GPER1, GPR119, HFE, IL6, IL17B, IL1RL2,
LPAR2, N-cor, NfkB1 RelA, PAX8, Proinsulin, RARRES2, S100A12,
SCAVENGER receptor CLASS A, SCN9A, SELENOS, SHBG, SMPDL3A, Timp,
TNF
T2
Cell-To-Cell Signaling and
Interaction, Cell Death and
Survival, Inflammatory
Response
21 7 Akt, ANGPTL1, B4GALT5, C4BPB, CHST3, CLEC10A, Collagen type VI, CRP,
Enolase, ERK, ERK1/2, EXT1, Fc gamma receptor, Fc receptor, FCER1A,
FCN1, FN1, GFRA2, HS6ST1, IL1, IL6, IL1RAP, ITIH3, miR-191-5p (and
other miRNAs w/seed AACGGAA), NFkB (complex), NfkB1-RelA, NRP1,
PRG4, PRSS38, pyridoxamine, S100A12, SEMA3D, SHBG, Stat3-Stat3,
TGFB1
P. Savedoroudi et al. / Data in brief 25 (2019) 104077 7variable modifications. A maximum of two tryptic missed cleavages was allowed. The false discovery
rate (FDR) of identified proteins and peptides was set to a maximum of 1%, using a target-decoy
fragment spectra search strategy. Hereby, high confidence identifications were ensured. The “match
between runs” feature was enabled to transfer peptide identifications across LC-MS/MS runs, based on
accurate retention time andmass-to-charge. The output fromMaxQuant, containing the list of proteins
identified below 1% FDR, was further filtered and processed in Perseus version 1.6.0.2 [6]. All reverse
hits and proteins identified only by site were removed from further analysis, and the data were log 2-
transformed. At least two unique peptides were required for a protein quantitation. Additionally, the
unique peptides were required to be quantifiable in at least 70% of samples.2.4. Bioinformatics analysis
Differentially regulated proteins between pre- and post-surgery subjects were functionally cate-
gorized based on gene ontology (GO) classification using WEB-based GEne SeT AnaLysis Toolkit
(WebGestalt) [7]. Identification of networks was performed with Ingenuity Pathway Analysis software
(IPA; Ingenuity Systems, Redwood City, CA, www.ingenuity.com). Gene symbols and the corresponding
protein fold change were imported to IPA software using core analysis. Standard settings in IPA were
employed, including: direct and indirect relationships between focused molecules with default
settings of 35 molecules/network, based on experimentally observed data (high confidence
P. Savedoroudi et al. / Data in brief 25 (2019) 1040778predictions and moderate confidence interactions excluded) were considered. All sources of data from
human, mouse and rat studies in the Ingenuity Knowledge Base were included.
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